New ACR president: Pharmacy benefit managers, artificial intelligence ‘must be regulated’
Although artificial intelligence presents “exciting opportunities,” its use in patient care “must be regulated” to address biases in decision making, said newly appointed American College of Rheumatology President Carol Langford, MD, MHS. “The interpretation of AI-provided data needs to be made in the context of each patient’s history, clinical presentation,